Eyenovia And Senju Partner On New Chronic Dry Eye Disease Treatment
23 Jul 2024 //
GLOBENEWSWIRE
Senju Pharmaceutical and Novaliq Enter Into License Agreement For NOV03
13 Jun 2023 //
BUSINESSWIRE
Launch of a New Combination Ophthalmic Solution for the Treatment of Glaucoma
16 Jun 2020 //
PRESS RELEASE
Prezista (darunavir) : Janssen Sc. Ireland vs. Amneal Pharma
20 Dec 2018 //
PATENT LITIGATION
Prolensa (Bromfenac) : Senju Pharmaceutical, B&L vs. Amneal Pharmaceuticals
10 Dec 2018 //
PATENT LITIGATION
Lexiscan (regadenoson) : Astellas Pharma, Gilead Sciences vs. Apotex
01 Nov 2018 //
PATENT LITIGATION
Jublia (efinaconazole) : Valeant Pharma, Dow Pharma, Kaken vs. Amneal Pharma
02 Oct 2018 //
PATENT LITIGATION
Prolensa®(bromfenac): Senju Pharmaceutical v. Amneal Pharmaceuticals
05 Apr 2018 //
PATENT LITIGATION
SemaThera announces licensing deal for China, Japan
26 Mar 2018 //
BIOSPECTRUM
SemaThera Announces a $2MUS Financing and a Licensing Deal for China and Japan
21 Mar 2018 //
BUSINESSWIRE
Allergan, Others Cough Up $9M In Product-Hopping Suit
16 Feb 2018 //
LAW360
Senju Pharmaceutical Co., Ltd. v. Lupin Ltd. (Fed. Cir. 2015)
31 Mar 2015 //
PATENT DOCS